Alnylam Pharmaceuticals, Inc. vs UnitedHealth Group Incorporated — Stock Comparison

ALNY
Alnylam Pharmaceuticals, Inc.
$296.11
▼ 4.32%
vs
UNH
UnitedHealth Group Incorporated
$368.78
▼ 0.46%
Q·Score Winner
Alnylam Pharmaceuticals, Inc.
ALNY8/10vs 6.3/10

Q·Score Breakdown

8
Bullish
Overall
6.3
Neutral
8.2
Quality
6.2
6.2
Health
5.3
8
Growth
5.1
9.7
Valuation
7.3
7.5
Sentiment
8.1
ALNY

Consensus analyst target of $449.48 is 52% above current price.

UNH

82% of 28 covering analysts have a positive rating.

limited growth momentum.

Analyst Consensus

BUY
Target $449.48 (+51.8%)
25 analysts
BUY
Target $387.27 (+5.0%)
26 analysts

Fundamentals

ALNY
UNH
74.6×
Trailing P/E
27.9×
21.2×
Forward P/E
17.8×
12.6%
Profit Margin
2.7%
80.8%
Gross Margin
18.8%
90.4%
ROE
12.2%
96.4%
Revenue Growth
2.0%
Earnings Growth
0.7%
0.38
Beta
0.41
Price / Book
$39.5B
Market Cap
$334.9B
$246 – $496
52-Week Range
$235 – $410

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →